| Title |
Single dose oral dexibuprofen [S(+)‐ibuprofen] for acute postoperative pain in adults
|
|---|---|
| Published in |
Cochrane database of systematic reviews, October 2013
|
| DOI | 10.1002/14651858.cd007550.pub3 |
| Pubmed ID | |
| Authors |
Sheena Derry, Jessica Best, R Andrew Moore |
| Abstract |
This review is an update of a previously published review in The Cochrane Database of Systematic Reviews Issue 3, 2009 on single dose oral dexibuprofen (S(+)-ibuprofen) for acute postoperative pain in adults.Dexibuprofen is a non-steroidal anti-inflammatory drug (NSAID) licensed for use in rheumatic disease and other musculoskeletal disorders in the UK, and widely available in other countries worldwide. It is an active isomer of ibuprofen. This review sought to evaluate the efficacy and safety of oral dexibuprofen in acute postoperative pain, using clinical studies in patients with established pain, and with outcomes measured primarily over four to six hours, using standard methods. This type of study has been used for many decades to establish that drugs have analgesic properties. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 157 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 157 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 28 | 18% |
| Student > Ph. D. Student | 17 | 11% |
| Student > Bachelor | 14 | 9% |
| Researcher | 10 | 6% |
| Student > Doctoral Student | 8 | 5% |
| Other | 28 | 18% |
| Unknown | 52 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 53 | 34% |
| Nursing and Health Professions | 11 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 5% |
| Psychology | 5 | 3% |
| Unspecified | 4 | 3% |
| Other | 15 | 10% |
| Unknown | 61 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 July 2015.
All research outputs
#7,387,249
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#8,415
of 11,842 outputs
Outputs of similar age
#64,012
of 224,892 outputs
Outputs of similar age from Cochrane database of systematic reviews
#156
of 215 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 11,842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.9. This one is in the 24th percentile – i.e., 24% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 224,892 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 215 others from the same source and published within six weeks on either side of this one. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.